loading
Schlusskurs vom Vortag:
$137.64
Offen:
$137.23
24-Stunden-Volumen:
39,683
Relative Volume:
0.05
Marktkapitalisierung:
$8.34B
Einnahmen:
$4.09B
Nettoeinkommen (Verlust:
$-404.84M
KGV:
-20.40
EPS:
-6.7469
Netto-Cashflow:
$1.24B
1W Leistung:
-1.23%
1M Leistung:
-1.33%
6M Leistung:
+14.64%
1J Leistung:
+24.60%
1-Tages-Spanne:
Value
$136.88
$138.21
1-Wochen-Bereich:
Value
$133.45
$139.73
52-Wochen-Spanne:
Value
$95.49
$148.06

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
Firmenname
Jazz Pharmaceuticals Plc
Name
Telefon
353-1-634-7800
Name
Adresse
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
Mitarbeiter
2,800
Name
Twitter
@jazzpharma
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
JAZZ's Discussions on Twitter

Vergleichen Sie JAZZ mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
137.56 8.35B 4.09B -404.84M 1.24B -6.7469
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
423.50 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.50 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
441.12 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
828.79 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.35 40.44B 447.02M -1.18B -868.57M -6.1812

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-15 Eingeleitet Deutsche Bank Buy
2025-03-07 Hochstufung UBS Neutral → Buy
2025-02-26 Herabstufung Cantor Fitzgerald Overweight → Neutral
2025-02-13 Hochstufung Wells Fargo Equal Weight → Overweight
2024-12-12 Hochstufung Morgan Stanley Equal-Weight → Overweight
2024-06-05 Eingeleitet Goldman Buy
2024-01-03 Eingeleitet Robert W. Baird Outperform
2023-11-27 Herabstufung UBS Buy → Neutral
2023-09-29 Eingeleitet Raymond James Mkt Perform
2023-06-12 Fortgesetzt Wells Fargo Equal Weight
2022-12-09 Hochstufung Goldman Neutral → Buy
2022-06-14 Eingeleitet UBS Buy
2022-04-06 Herabstufung Goldman Buy → Neutral
2021-11-19 Fortgesetzt Goldman Buy
2021-10-07 Fortgesetzt Jefferies Buy
2021-10-05 Eingeleitet Citigroup Buy
2021-09-23 Eingeleitet Needham Buy
2021-05-19 Fortgesetzt JP Morgan Overweight
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2021-02-05 Bestätigt H.C. Wainwright Buy
2021-02-03 Hochstufung Piper Sandler Neutral → Overweight
2021-01-29 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-12-16 Eingeleitet UBS Buy
2020-11-03 Bestätigt H.C. Wainwright Buy
2020-10-09 Bestätigt H.C. Wainwright Buy
2020-09-14 Herabstufung Goldman Neutral → Sell
2020-09-14 Fortgesetzt JP Morgan Overweight
2020-08-06 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-07-28 Hochstufung Wolfe Research Peer Perform → Outperform
2020-07-23 Hochstufung H.C. Wainwright Neutral → Buy
2020-04-06 Eingeleitet Jefferies Buy
2020-03-12 Hochstufung Bernstein Mkt Perform → Outperform
2020-01-08 Eingeleitet Goldman Neutral
2019-08-21 Herabstufung Piper Jaffray Overweight → Neutral
2019-06-11 Eingeleitet Barclays Overweight
2019-03-20 Eingeleitet SunTrust Buy
2018-12-14 Eingeleitet Wolfe Research Peer Perform
2018-11-08 Bestätigt B. Riley FBR Buy
2018-08-08 Bestätigt Stifel Buy
2018-07-11 Herabstufung Morgan Stanley Overweight → Equal-Weight
2018-03-23 Bestätigt H.C. Wainwright Neutral
2018-03-19 Hochstufung Morgan Stanley Equal-Weight → Overweight
Alle ansehen

Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten

pulisher
08:13 AM

Live market analysis of Jazz Pharmaceuticals plcBond Market & Fast Entry Momentum Trade Alerts - newser.com

08:13 AM
pulisher
06:42 AM

Why Jazz Pharmaceuticals plc stock is trending among retail tradersTrade Entry Summary & Weekly Watchlist of Top Performers - newser.com

06:42 AM
pulisher
06:11 AM

Will Jazz Pharmaceuticals plc (J7Z) stock outperform benchmarksGDP Growth & Safe Entry Trade Reports - newser.com

06:11 AM
pulisher
05:35 AM

Can Jazz Pharmaceuticals plc stock resist sector downturnsJuly 2025 Fed Impact & Daily Stock Trend Reports - newser.com

05:35 AM
pulisher
01:23 AM

Can Jazz Pharmaceuticals plc stock hit record highs againMarket Activity Recap & Risk Controlled Stock Pick Alerts - newser.com

01:23 AM
pulisher
Nov 02, 2025

Best data tools to analyze Jazz Pharmaceuticals plc stock2025 Big Picture & AI Powered Trade Plan Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How Jazz Pharmaceuticals plc (J7Z) stock performs in easing cyclesMarket Activity Summary & Entry Point Strategy Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What Jazz Pharmaceuticals (JAZZ)'s Cross-Licensing Settlement With Avadel Means For Shareholder Value - Yahoo! Finance UK

Nov 02, 2025
pulisher
Nov 02, 2025

Assetmark Inc. Purchases 82,275 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

Are Jazz Pharmaceuticals Shares Still Attractive After a 25% Climb and New Pipeline Developments? - simplywall.st

Nov 02, 2025
pulisher
Nov 01, 2025

Why Jazz Pharmaceuticals plc (J7Z) stock could be next leaderJuly 2025 Closing Moves & Precise Buy Zone Tips - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Multi factor analysis applied to Jazz Pharmaceuticals plc2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

How Jazz Pharmaceuticals plc stock trades during market volatilityJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Jazz Pharmaceuticals PLC $JAZZ Shares Purchased by Kovack Advisors Inc. - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Statistical indicators supporting Jazz Pharmaceuticals plc’s strengthJuly 2025 Setups & AI Enhanced Trading Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Impact Partnership Wealth LLC Takes Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

When is the best time to exit Jazz Pharmaceuticals plcJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

How Investors May Respond To Jazz Pharmaceuticals (JAZZ) Settling Global LUMRYZ Patent Dispute with Avadel - simplywall.st

Nov 01, 2025
pulisher
Oct 31, 2025

Is Jazz Pharmaceuticals plc (J7Z) stock a momentum leaderTrade Ideas & Long-Term Investment Growth Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How strong is Jazz Pharmaceuticals plc stock revenue growthTrade Risk Assessment & Fast Gain Stock Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why Jazz Pharmaceuticals plc stock is seen as undervalued2025 Growth vs Value & AI Powered Market Entry Strategies - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Jazz Pharmaceuticals plc stock outlook for YEARJuly 2025 Outlook & Fast Entry High Yield Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Jazz Pharmaceuticals plc stock a buy before product launchesJuly 2025 Summary & Daily Technical Forecast Reports - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Jazz Pharmaceuticals plc (JAZZ) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Jazz Pharmaceuticals (JAZZ) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Will Jazz Pharmaceuticals plc stock see PE expansionWeekly Profit Recap & High Win Rate Trade Tips - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Jazz Pharmaceuticals plc (JAZZ) Stock forecasts - Yahoo! Finance UK

Oct 29, 2025
pulisher
Oct 29, 2025

What Technical Volume Patterns Indicate for Hinduja Global Solutions LimitedLong-Term Investment Plans & High Yield Investment Portfolio - earlytimes.in

Oct 29, 2025
pulisher
Oct 29, 2025

Jazz Pharmaceuticals plc (JAZZ) Stock Forecasts - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

JAZZ (Jazz Pharmaceuticals) Forward Rate of Return (Yacktma - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Earnings Preview: Jazz Pharmaceuticals (JAZZ) Q3 Earnings Expected to Decline - Yahoo Finance

Oct 29, 2025

Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.33
price down icon 0.21%
$92.90
price down icon 0.29%
$28.82
price up icon 0.74%
$104.39
price up icon 0.46%
biotechnology ONC
$312.52
price up icon 0.95%
$182.24
price down icon 3.63%
Kapitalisierung:     |  Volumen (24h):